Complete financial analysis of Smruthi Organics Limited (SMRUTHIORG.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Smruthi Organics Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Quarta-Rad, Inc. (QURT) Income Statement Analysis – Financial Results
- Calidus Resources Limited (CALRF) Income Statement Analysis – Financial Results
- Scope Fluidics S.A. (SCP.WA) Income Statement Analysis – Financial Results
- AmidA Holdings Co.,Ltd. (7671.T) Income Statement Analysis – Financial Results
- Sydinvest Mellemlange Obligationer Akk (SYIMOADKKA.CO) Income Statement Analysis – Financial Results
Smruthi Organics Limited (SMRUTHIORG.BO)
About Smruthi Organics Limited
Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. Its products include amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. The company was founded by Purushotham Mallayya Eaga on July 11, 1989 and is headquartered in Solapur, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.41B | 1.33B | 1.24B | 1.29B | 1.35B | 959.62M | 778.76M | 725.80M | 748.05M | 918.29M | 1.80B | 2.05B | 1.57B | 1.27B | 745.11M | 567.44M | 545.64M |
| Cost of Revenue | 693.24M | 937.52M | 821.60M | 683.30M | 853.28M | 925.39M | 618.48M | 494.65M | 425.25M | 530.59M | 663.47M | 1.32B | 1.54B | 1.17B | 1.04B | 582.04M | 430.11M | 414.18M |
| Gross Profit | 575.66M | 468.79M | 507.52M | 559.59M | 439.11M | 428.53M | 341.15M | 284.11M | 300.55M | 217.45M | 254.82M | 480.26M | 510.99M | 406.25M | 226.09M | 163.06M | 137.33M | 131.46M |
| Gross Profit Ratio | 45.37% | 33.33% | 38.18% | 45.02% | 33.98% | 31.65% | 35.55% | 36.48% | 41.41% | 29.07% | 27.75% | 26.67% | 24.91% | 25.82% | 17.81% | 21.88% | 24.20% | 24.09% |
| Research & Development | 9.12M | 5.73M | 6.64M | 4.05M | 4.53M | 1.32M | 140.05K | 344.79K | 488.16K | 171.53K | 10.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 90.02M | 0.00 | 0.00 | 39.82M | 104.26M | 77.90M | 60.34M | 52.91M |
| Selling & Marketing | 21.84M | 13.12M | 11.08M | 8.58M | 10.17M | 13.33M | 10.71M | 6.49M | 11.42M | 11.42M | 11.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 21.84M | 13.12M | 11.08M | 8.58M | 10.17M | 13.33M | 10.71M | 6.49M | 11.42M | 11.42M | 101.03M | 0.00 | 0.00 | 39.82M | 104.26M | 77.90M | 60.34M | 52.91M |
| Other Expenses | 488.90M | 199.00K | 5.83M | 5.61M | 516.61K | 382.11K | 316.29K | 6.95M | 0.00 | 0.00 | 0.00 | 4.06M | 2.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 519.86M | 416.70M | 365.80M | 313.72M | 324.08M | 298.56M | 269.51M | 224.19M | 235.40M | 219.16M | 298.69M | 343.32M | 298.73M | 225.88M | 110.77M | 103.63M | 81.96M | 77.02M |
| Cost & Expenses | 1.21B | 1.35B | 1.19B | 997.02M | 1.18B | 1.22B | 887.99M | 718.84M | 660.65M | 749.75M | 962.16M | 1.66B | 1.84B | 1.39B | 1.15B | 685.68M | 512.07M | 491.21M |
| Interest Income | 671.00K | 874.00K | 5.83M | 4.94M | 2.58M | 3.11M | 1.69M | 2.81M | 1.94M | 1.38M | 933.45K | 1.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.09M | 3.79M | 4.76M | 6.50M | 25.42M | 28.06M | 34.86M | 38.84M | 45.56M | 49.46M | 46.94M | 33.18M | 54.01M | 44.25M | 42.77M | 40.90M | 34.41M | 23.39M |
| Depreciation & Amortization | 53.49M | 45.72M | 42.56M | 39.46M | 43.86M | 41.35M | 40.66M | 39.66M | 43.30M | 48.04M | 59.86M | 52.91M | 452.96 | 39.82M | 38.25M | 31.21M | 29.88M | 29.22M |
| EBITDA | 116.32M | 99.34M | 190.12M | 285.33M | 159.42M | 174.72M | 34.69M | 99.57M | 105.94M | 40.93M | 15.99M | 189.84M | 257.55M | 208.99M | 153.57M | 90.64M | 85.25M | 83.66M |
| EBITDA Ratio | 9.17% | 6.72% | 13.92% | 23.05% | 11.54% | 12.33% | 11.28% | 13.41% | 14.43% | 5.47% | 1.76% | 10.54% | 12.55% | 11.46% | 12.09% | 12.16% | 15.02% | 15.33% |
| Operating Income | 63.03M | 49.32M | 144.49M | 231.07M | 103.33M | 104.38M | -21.86M | 52.08M | 54.01M | -7.11M | -43.72M | 136.94M | 257.55M | 140.55M | 115.32M | 59.43M | 55.37M | 54.44M |
| Operating Income Ratio | 4.97% | 3.51% | 10.87% | 18.59% | 8.00% | 7.71% | -2.28% | 6.69% | 7.44% | -0.95% | -4.76% | 7.61% | 12.55% | 8.93% | 9.08% | 7.98% | 9.76% | 9.98% |
| Total Other Income/Expenses | -13.33M | -4.38M | -6.77M | 9.48M | 5.88M | -32.40M | -118.48M | -33.98M | -38.10M | -54.86M | -39.84M | -36.11M | -97.11M | -44.25M | -42.77M | -40.90M | -34.41M | -23.70M |
| Income Before Tax | 49.70M | 44.94M | 137.72M | 240.55M | 120.91M | 97.57M | -46.84M | 25.93M | 15.90M | -56.57M | -90.67M | 100.83M | 160.44M | 136.12M | 72.55M | 18.53M | 20.96M | 31.05M |
| Income Before Tax Ratio | 3.92% | 3.20% | 10.36% | 19.35% | 9.36% | 7.21% | -4.88% | 3.33% | 2.19% | -7.56% | -9.87% | 5.60% | 7.82% | 8.65% | 5.71% | 2.49% | 3.69% | 5.69% |
| Income Tax Expense | 13.79M | 3.63M | 33.90M | 69.48M | 36.44M | 28.95M | -14.71M | 10.08M | 8.67M | -18.43M | -29.15M | 37.30M | 54.04M | 39.11M | 17.06M | 3.61M | 2.08M | 7.66M |
| Net Income | 35.90M | 41.31M | 103.82M | 171.07M | 84.47M | 68.62M | -32.13M | 15.85M | 7.23M | -38.14M | -61.52M | 63.53M | 106.40M | 97.01M | 55.49M | 14.92M | 18.89M | 23.39M |
| Net Income Ratio | 2.83% | 2.94% | 7.81% | 13.76% | 6.54% | 5.07% | -3.35% | 2.04% | 1.00% | -5.10% | -6.70% | 3.53% | 5.19% | 6.17% | 4.37% | 2.00% | 3.33% | 4.29% |
| EPS | 3.14 | 3.61 | 9.07 | 14.95 | 7.38 | 5.99 | -2.81 | 1.38 | 0.63 | -3.33 | -5.37 | 5.55 | 0.09 | 8.48 | 4.87 | 1.31 | 1.66 | 2.05 |
| EPS Diluted | 3.14 | 3.61 | 9.07 | 14.95 | 7.38 | 5.99 | -2.81 | 1.38 | 0.63 | -3.33 | -5.37 | 5.55 | 0.09 | 8.48 | 4.87 | 1.31 | 1.66 | 2.05 |
| Weighted Avg Shares Out | 11.43M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.42M | 11.44M | 11.45M | 11.40M | 11.45M | 11.45M | 11.40M | 11.40M | 11.40M | 11.40M |
| Weighted Avg Shares Out (Dil) | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.46M | 11.42M | 11.44M | 11.45M | 11.40M | 11.45M | 11.45M | 11.40M | 11.40M | 11.40M | 11.40M |
No news found for: SMRUTHIORG.BO
Source: https://incomestatements.info
Category: Stock Reports